Ok, so the report likely none of you have been waiting for is now out! Yes, I’m talking about EB154/29 Rev 1, 21st December 2023, aka Sustainable financing: WHO investment round. Report by the Director-General. I’ve written previously about WHO’s new financing mechanism, due to launch in the second half of 2024 (to nicely coincide with the re-election of Trump as President of the US – WHO’s biggest funder). The latest thinking on this new funding mechanism is detailed in this report, with a specific focus on the Investment Round (IR). Below are some thoughts on this report. As ever, I add the caveat that I don’t know what I’m talking about, so you should not just take my word for it (i.e. you’re gonna’ have to read the report yourself).
Purpose and vision for success
Under the heading ‘Purpose and vision for success’ the report tells us that the “WHO investment round aims to safeguard the global political momentum for health in order to rally stakeholders behind the General Program of Work 14 and move the Organization’s finances towards more predictability and flexibility”. It’s worth noting that, typically, the base segment gets fully financed, eventually. So, it’s never really been a problem to ‘rally’ ‘stakeholders’ behind the GPW. It could now become a problem, depending on whether the IR is a success or not. Also worth noting that the sums of money involved are tiny, so it’s unlikely (I hope) to deter funders. The returns in fully funding the base segment are, of course, very significant as have been painstakingly described by WHO in its 2022 investment case A Healthy Return.
Below are a couple of quotes from the IR report.
The success of the WHO investment round will not be measured solely by the funding raised but will also take into account predictability, flexibility, broadening of the donor base and increased efficiency.
Para 8
With regard to predictability, important markers will be the funding that is available through voluntary contributions at the beginning of the four-year period of the GPW 14 (baseline for the period 2020–2023: 17%) and the number of contributors pledging for the full four-year period (baseline for 2020–2023: seven).
Para 9
The amount of funding raised by IR is crucial, so it feels as though the Secretariat is covering its bases here. If it does less well in raising money than the current arrangement, then it should be judged a failure regardless of whether the funding is more predictable/flexible/broader donor base. The likelihood of the IR securing more flexible funding is quite low, for reasons described in my earlier post. The flexibility will mostly be achieved by the increase in ACs. Nevertheless, it remains the aim (despite US efforts to wriggle out of its commitments) for the base segment to be fully flexible, so it’s important that the quality of VCs shifts to being more flexible.
Markers/indicators of success
The first marker – raise17% of the total VCs at the beginning of the period. We know from the draft GPW 14 that the “indicative financial envelope” is around US$11.13bn for the period 2025-2028 of which US$7.14bn in VCs will have to be raised through the IR. 17% would = US$1.21bn. We know from EB154/27 Table 4 that the projected VCs for 2024-25 are US$1.28bn, so achieving an extra US$70m doesn’t seem too much of a stretch, does it? This marker is already in the bag.
The second marker, seven contributors, also seems on the face of it relatively easy to secure. Multi-year commitments of VCs to the Program budget from donors are actually on the increase – rising from US$818m in 2022 to US$964m in 2023 (A76/17, p10). The table below lists the top ten contributors to the base segment. It will be very interesting to see who of these will pledge for the duration of the GPW. Given the amount of money each of the top five contribute, not getting their commitment will mean that the amount of money secured for the period will be relatively low, undermining the potential utility of predictable funds.
Let’s look at some more markers: “With regard to flexibility, the indicator will be the percentage of available voluntary flexible funding for the base budget for the four-year period (baseline for 2020–2023: 16%)”. Again, unless you’re familiar with the different kinds of VCs, this might be confusing. The least flexible VCs are ‘specified’ or ‘earmarked’ VCs, which contribute most of the VCs to the base segment. There are also ‘thematic’ and ‘core’ VCs. Core VCs are the most flexible and are often referred to as ‘flexible’ VCs for that reason. To get a sense of the relative weighting of these VCs see the figure below from A76/17. The 16% marker is going to be quite a challenge. As A76/17 points out: “The proportion of flexible and thematic funding decreased by US$ 140 million from US$ 464 million in 2021 to US$ 324 million in 2022, which represents just 9% of total voluntary contributions”. But I guess that this is part of the reason why the IR has been set up. Nevertheless, my feeling is that it will struggle to meet this target.
There’s one final marker or indicator of success: broadening the donor base. Here’s the text: “Finally, the number of contributors that increase the amount of their contributions will demonstrate not only the broadening of the donor base but also the commitment of existing donors”. I don’t know whether it’s the way it’s phrased, but it sounds to me like ‘broadening the donor base’ does not necessarily mean increasing the number of donors. It looks like the ‘broadening’ condition is satisfied if more existing donors increase their contributions. That might demonstrate an increase in commitment but does it really demonstrate a broadening of the donor base?
Modalities
The report gives us some more information about how the IR will proceed. Here’s the description: “The event, which will provide an opportunity for all Member States and other contributors to participate, virtually or in person, and to make financial pledges to the GPW 14 base budget”. Tedros introduced ‘investment cases’ when he took the helm as DG as a way to secure donor support. He launched the first investment case in 2018 and clearly articulated the economic case in the 2022 report A Healthy return. A new investment case is being developed for the IR building on previous cases. It’s hard to see why this is necessary. Personally, I find the need for the DG to provide an ‘investment case’ to donors absurd. The WHO is a global public good and is necessary for international health cooperation. The ‘case’ for WHO, in my opinion, is self-evident. I’d also repeat, for anyone who cares to listen, that the amounts of money we are talking about are MINISCULE. Note to donors and especially Member States – pay up already and stop fucking around.
Resource mobilisation
We know how much money the IR will have to secure (remember, it is only concerned with funding the base segment of the budget) (see Table 2 of EB154/29 Rev 1 for the indicative financial envelope). Of the total US$11.13bn for 2025-28, US$7.13bn will need to come VCs. Ensuring the IR delivers – will be done by a combination of senior level MS chivvying; including in the account any VCs already committed for the period (see above); broadening the definition of ‘thematic’ funding to include greater programmatic and geographical flexibility; a review of the Resource Allocation Committee’s operations; and the rollout of a standardised report template.
Costs and benefits of the IR
A CBA was conducted (I don’t think that this is in the public domain, but should be). Costs: because “WHO’s resource mobilization capacities are already lean” there won’t be much additional cost but “the potential for organizational efficiencies and increased effectiveness is significant”. Lol – I love how the report makes a negative (WHO doesn’t have much capacity to mobilise resources – 87 dedicated staff) into a positive! In monetary terms, the overall cost of the IR will be in the range of US$ 3.25-5.55m. Efficiency savings, on the other hand, will be in the range of US$15-40m + unquantified benefits of staff retention from more predictable funding.
Risks
The three risks with the greatest impact and probability are: (a) the financial risk of not meeting the target; (b) the reputational risk of the investment round being portrayed as a failure; and (c) the structural risk of WHO’s resource mobilization approach not being optimized for an investment round.
These are serious risks – existential even. And, to return to my flippant point at the start of the post, could be realised under a Trump Presidency. I don’t find the mitigation strategy particularly convincing: “having a clear set of indicators for success beyond simply the total amount raised; leveraging the unique strength of WHO’s resource mobilization approach; and having a strong results framework and investment case with a clear communication plan”. You can see why the indicators are developed in the way they are – deliberately not dependent on total moneys raised (even though this is really important). The report makes a lot of the ‘lean-ness’ of WHO’s resource mobilisation capacity, so I’m not sure how it can also then leverage its “unique strength”?
Sure, there will be a results framework and there will be an investment case, and all that. But, why is the Secretariat required to go to such extraordinary lengths to secure funding to an IO with such an obvious benefit to all of our lives? It. Is. Madness. There’s a potential storm coming at the end of 2024, and it feels like WHO is going to be very exposed and vulnerable when/if that storm breaks. I just hope it has a contingency plan.
Andrew
For more on this, see Priti Patnaik’s analysis over on Geneva Health Files:
https://genevahealthfiles.substack.com/p/who-replenishment-investment-round-billion-2024